<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-11-01" modified="2020-10-07" version="226">
<accession>P19338</accession>
<accession>Q53SK1</accession>
<accession>Q8NB06</accession>
<accession>Q9UCF0</accession>
<accession>Q9UDG1</accession>
<name>NUCL_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nucleolin</fullName>
</recommendedName>
<alternativeName>
<fullName>Protein C23</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NCL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1989" name="FEBS Lett." volume="250" first="99" last="105">
<title>Cloning and sequencing of the human nucleolin cDNA.</title>
<authorList>
<person name="Srivastava M."/>
<person name="Fleming P.J."/>
<person name="Pollard H.B."/>
<person name="Burns A.L."/>
</authorList>
<dbReference type="PubMed" id="2737305"/>
<dbReference type="DOI" id="10.1016/0014-5793(89)80692-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Retina</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="14922" last="14931">
<title>Genomic organization and chromosomal localization of the human nucleolin gene.</title>
<authorList>
<person name="Srivastava M."/>
<person name="McBride O.W."/>
<person name="Fleming P.J."/>
<person name="Pollard H.B."/>
<person name="Burns A.L."/>
</authorList>
<dbReference type="PubMed" id="2394707"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Hair follicle dermal papilla</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="Biochim. Biophys. Acta" volume="1266" first="109" last="112">
<title>Purification and partial amino acid sequencing of a fructosyllysine-specific binding protein from cell membranes of the monocyte-like cell line U937.</title>
<authorList>
<person name="Krantz S."/>
<person name="Salazar R."/>
<person name="Brandt R."/>
<person name="Kellermann J."/>
<person name="Lottspeich F."/>
</authorList>
<dbReference type="PubMed" id="7718615"/>
<dbReference type="DOI" id="10.1016/0167-4889(95)00028-q"/>
</citation>
<scope>PROTEIN SEQUENCE OF 2-7; 349-362 AND 610-624</scope>
<source>
<tissue>Lymphoma</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1994" name="Biochemistry" volume="33" first="14696" last="14706">
<title>Major cell surface-located protein substrates of an ecto-protein kinase are homologs of known nuclear proteins.</title>
<authorList>
<person name="Jordan P."/>
<person name="Heid H."/>
<person name="Kinzel V."/>
<person name="Kubler D."/>
</authorList>
<dbReference type="PubMed" id="7993898"/>
<dbReference type="DOI" id="10.1021/bi00253a007"/>
</citation>
<scope>PROTEIN SEQUENCE OF 231-236; 349-362; 399-403; 458-461 AND 649-653</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1993" name="Mol. Cell. Biol." volume="13" first="4301" last="4310">
<title>Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)n.</title>
<authorList>
<person name="Ishikawa F."/>
<person name="Matunis M.J."/>
<person name="Dreyfuss G."/>
<person name="Cech T.R."/>
</authorList>
<dbReference type="PubMed" id="8321232"/>
<dbReference type="DOI" id="10.1128/mcb.13.7.4301"/>
</citation>
<scope>PROTEIN SEQUENCE OF 458-474</scope>
<scope>NUCLEOTIDE-BINDING</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
<title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
<authorList>
<person name="Parada C.A."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="10393184"/>
<dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POLYMERASE II; SUPT5H AND CDK9</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="37492" last="37502">
<title>The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor.</title>
<authorList>
<person name="Said E.A."/>
<person name="Krust B."/>
<person name="Nisole S."/>
<person name="Svab J."/>
<person name="Briand J.P."/>
<person name="Hovanessian A.G."/>
</authorList>
<dbReference type="PubMed" id="12147681"/>
<dbReference type="DOI" id="10.1074/jbc.m201194200"/>
</citation>
<scope>INTERACTION WITH MDK</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="Mol. Biol. Cell" volume="13" first="4100" last="4109">
<title>Functional proteomic analysis of human nucleolus.</title>
<authorList>
<person name="Scherl A."/>
<person name="Coute Y."/>
<person name="Deon C."/>
<person name="Calle A."/>
<person name="Kindbeiter K."/>
<person name="Sanchez J.-C."/>
<person name="Greco A."/>
<person name="Hochstrasser D.F."/>
<person name="Diaz J.-J."/>
</authorList>
<dbReference type="PubMed" id="12429849"/>
<dbReference type="DOI" id="10.1091/mbc.e02-05-0271"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Hum. Mol. Genet." volume="13" first="1081" last="1093">
<title>Aprataxin, a novel protein that protects against genotoxic stress.</title>
<authorList>
<person name="Gueven N."/>
<person name="Becherel O.J."/>
<person name="Kijas A.W."/>
<person name="Chen P."/>
<person name="Howe O."/>
<person name="Rudolph J.H."/>
<person name="Gatti R."/>
<person name="Date H."/>
<person name="Onodera O."/>
<person name="Taucher-Scholz G."/>
<person name="Lavin M.F."/>
</authorList>
<dbReference type="PubMed" id="15044383"/>
<dbReference type="DOI" id="10.1093/hmg/ddh122"/>
</citation>
<scope>INTERACTION WITH APTX</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="51508" last="51515">
<title>Nucleolin interacts with telomerase.</title>
<authorList>
<person name="Khurts S."/>
<person name="Masutomi K."/>
<person name="Delgermaa L."/>
<person name="Arai K."/>
<person name="Oishi N."/>
<person name="Mizuno H."/>
<person name="Hayashi N."/>
<person name="Hahn W.C."/>
<person name="Murakami S."/>
</authorList>
<dbReference type="PubMed" id="15371412"/>
<dbReference type="DOI" id="10.1074/jbc.m407643200"/>
</citation>
<scope>INTERACTION WITH TERT</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145; SER-153 AND SER-563</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-580</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Electrophoresis" volume="28" first="2027" last="2034">
<title>Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line.</title>
<authorList>
<person name="Giorgianni F."/>
<person name="Zhao Y."/>
<person name="Desiderio D.M."/>
<person name="Beranova-Giorgianni S."/>
</authorList>
<dbReference type="PubMed" id="17487921"/>
<dbReference type="DOI" id="10.1002/elps.200600782"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-145; SER-153; SER-184 AND SER-206</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Prostate cancer</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Exp. Cell Res." volume="313" first="3755" last="3766">
<title>Nucleolin modulates the subcellular localization of GDNF-inducible zinc finger protein 1 and its roles in transcription and cell proliferation.</title>
<authorList>
<person name="Dambara A."/>
<person name="Morinaga T."/>
<person name="Fukuda N."/>
<person name="Yamakawa Y."/>
<person name="Kato T."/>
<person name="Enomoto A."/>
<person name="Asai N."/>
<person name="Murakumo Y."/>
<person name="Matsuo S."/>
<person name="Takahashi M."/>
</authorList>
<dbReference type="PubMed" id="17674968"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2007.07.003"/>
</citation>
<scope>INTERACTION WITH GZF1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="J. Proteome Res." volume="6" first="4150" last="4162">
<title>Improved titanium dioxide enrichment of phosphopeptides from HeLa cells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.</title>
<authorList>
<person name="Yu L.R."/>
<person name="Zhu Z."/>
<person name="Chan K.C."/>
<person name="Issaq H.J."/>
<person name="Dimitrov D.S."/>
<person name="Veenstra T.D."/>
</authorList>
<dbReference type="PubMed" id="17924679"/>
<dbReference type="DOI" id="10.1021/pr070152u"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-76 AND THR-121</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="1107" last="1117">
<title>Aurora-B regulates RNA methyltransferase NSUN2.</title>
<authorList>
<person name="Sakita-Suto S."/>
<person name="Kanda A."/>
<person name="Suzuki F."/>
<person name="Sato S."/>
<person name="Takata T."/>
<person name="Tatsuka M."/>
</authorList>
<dbReference type="PubMed" id="17215513"/>
<dbReference type="DOI" id="10.1091/mbc.e06-11-1021"/>
</citation>
<scope>INTERACTION WITH NSUN2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Mol. Cell. Proteomics" volume="6" first="798" last="811">
<title>Molecular composition of IMP1 ribonucleoprotein granules.</title>
<authorList>
<person name="Joeson L."/>
<person name="Vikesaa J."/>
<person name="Krogh A."/>
<person name="Nielsen L.K."/>
<person name="Hansen T."/>
<person name="Borup R."/>
<person name="Johnsen A.H."/>
<person name="Christiansen J."/>
<person name="Nielsen F.C."/>
</authorList>
<dbReference type="PubMed" id="17289661"/>
<dbReference type="DOI" id="10.1074/mcp.m600346-mcp200"/>
</citation>
<scope>IDENTIFICATION IN A MRNP GRANULE COMPLEX</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69; SER-184; SER-206 AND THR-214</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="28660" last="28673">
<title>The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.</title>
<authorList>
<person name="Crawford N.P."/>
<person name="Yang H."/>
<person name="Mattaini K.R."/>
<person name="Hunter K.W."/>
</authorList>
<dbReference type="PubMed" id="19710015"/>
<dbReference type="DOI" id="10.1074/jbc.m109.023457"/>
</citation>
<scope>INTERACTION WITH RRP1B</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-34 AND THR-301</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-9; LYS-102; LYS-116; LYS-124; LYS-318; LYS-377; LYS-398; LYS-403; LYS-513; LYS-572; LYS-577 AND LYS-646</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Mol. Cancer Res." volume="8" first="1388" last="1398">
<title>Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.</title>
<authorList>
<person name="Gilmore-Hebert M."/>
<person name="Ramabhadran R."/>
<person name="Stern D.F."/>
</authorList>
<dbReference type="PubMed" id="20858735"/>
<dbReference type="DOI" id="10.1158/1541-7786.mcr-10-0042"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>INTERACTION WITH ERBB4</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E9588" last="E9588">
<title>Phosphorylation of human tristetraprolin in response to its interaction with the Cbl interacting protein CIN85.</title>
<authorList>
<person name="Kedar V.P."/>
<person name="Darby M.K."/>
<person name="Williams J.G."/>
<person name="Blackshear P.J."/>
</authorList>
<dbReference type="PubMed" id="20221403"/>
<dbReference type="DOI" id="10.1371/journal.pone.0009588"/>
</citation>
<scope>INTERACTION WITH ZFP36</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28; SER-34; SER-67; THR-69; THR-76; THR-84; THR-92; THR-99; THR-106; THR-113; THR-121; SER-145; SER-563 AND SER-619</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="1976" last="1986">
<title>RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.</title>
<authorList>
<person name="Guderian G."/>
<person name="Peter C."/>
<person name="Wiesner J."/>
<person name="Sickmann A."/>
<person name="Schulze-Osthoff K."/>
<person name="Fischer U."/>
<person name="Grimmler M."/>
</authorList>
<dbReference type="PubMed" id="21081503"/>
<dbReference type="DOI" id="10.1074/jbc.m110.148486"/>
</citation>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH RIOK1</scope>
<scope>METHYLATION BY PRTM5</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="21732" last="21741">
<title>Structure and function of the N-terminal nucleolin binding domain of nuclear valosin-containing protein-like 2 (NVL2) harboring a nucleolar localization signal.</title>
<authorList>
<person name="Fujiwara Y."/>
<person name="Fujiwara K."/>
<person name="Goda N."/>
<person name="Iwaya N."/>
<person name="Tenno T."/>
<person name="Shirakawa M."/>
<person name="Hiroaki H."/>
</authorList>
<dbReference type="PubMed" id="21474449"/>
<dbReference type="DOI" id="10.1074/jbc.m110.174680"/>
</citation>
<scope>INTERACTION WITH NVL</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="J. Cell Sci." volume="124" first="394" last="404">
<title>The nuclear scaffold protein SAF-A is required for kinetochore-microtubule attachment and contributes to the targeting of Aurora-A to mitotic spindles.</title>
<authorList>
<person name="Ma N."/>
<person name="Matsunaga S."/>
<person name="Morimoto A."/>
<person name="Sakashita G."/>
<person name="Urano T."/>
<person name="Uchiyama S."/>
<person name="Fukui K."/>
</authorList>
<dbReference type="PubMed" id="21242313"/>
<dbReference type="DOI" id="10.1242/jcs.063347"/>
</citation>
<scope>INTERACTION WITH HNRNPU</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Mol. Cell" volume="42" first="794" last="805">
<title>Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.</title>
<authorList>
<person name="Skourti-Stathaki K."/>
<person name="Proudfoot N.J."/>
<person name="Gromak N."/>
</authorList>
<dbReference type="PubMed" id="21700224"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.04.026"/>
</citation>
<scope>INTERACTION WITH SETX</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2011" name="Mol. Cell. Proteomics" volume="10">
<title>Splicing factor 2-associated protein p32 participates in ribosome biogenesis by regulating the binding of Nop52 and fibrillarin to preribosome particles.</title>
<authorList>
<person name="Yoshikawa H."/>
<person name="Komatsu W."/>
<person name="Hayano T."/>
<person name="Miura Y."/>
<person name="Homma K."/>
<person name="Izumikawa K."/>
<person name="Ishikawa H."/>
<person name="Miyazawa N."/>
<person name="Tachikawa H."/>
<person name="Yamauchi Y."/>
<person name="Isobe T."/>
<person name="Takahashi N."/>
</authorList>
<dbReference type="PubMed" id="21536856"/>
<dbReference type="DOI" id="10.1074/mcp.m110.006148"/>
</citation>
<scope>INTERACTION WITH C1QBP</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-69; SER-563; SER-580 AND SER-619</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="Genes Cells" volume="18" first="780" last="797">
<title>Nucleolar scaffold protein, WDR46, determines the granular compartmental localization of nucleolin and DDX21.</title>
<authorList>
<person name="Hirai Y."/>
<person name="Louvet E."/>
<person name="Oda T."/>
<person name="Kumeta M."/>
<person name="Watanabe Y."/>
<person name="Horigome T."/>
<person name="Takeyasu K."/>
</authorList>
<dbReference type="PubMed" id="23848194"/>
<dbReference type="DOI" id="10.1111/gtc.12077"/>
</citation>
<scope>INTERACTION WITH WDR46</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-76; THR-121; SER-145; SER-153; SER-184; SER-206; SER-356; THR-367; THR-405; SER-458; SER-460; SER-563; SER-580 AND SER-619</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-42; SER-67; SER-184; SER-580; SER-591 AND SER-619</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="PLoS ONE" volume="9" first="E91465" last="E91465">
<title>Subcellular fractionation and localization studies reveal a direct interaction of the fragile X mental retardation protein (FMRP) with nucleolin.</title>
<authorList>
<person name="Taha M.S."/>
<person name="Nouri K."/>
<person name="Milroy L.G."/>
<person name="Moll J.M."/>
<person name="Herrmann C."/>
<person name="Brunsveld L."/>
<person name="Piekorz R.P."/>
<person name="Ahmadian M.R."/>
</authorList>
<dbReference type="PubMed" id="24658146"/>
<dbReference type="DOI" id="10.1371/journal.pone.0091465"/>
</citation>
<scope>INTERACTION WITH FMR1</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-297; LYS-324 AND LYS-589</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2016" name="Biol. Chem." volume="397" first="417" last="436">
<title>Two new isoforms of the human hepatoma-derived growth factor interact with components of the cytoskeleton.</title>
<authorList>
<person name="Nuesse J."/>
<person name="Mirastschijski U."/>
<person name="Waespy M."/>
<person name="Oetjen J."/>
<person name="Brandes N."/>
<person name="Rebello O."/>
<person name="Paroni F."/>
<person name="Kelm S."/>
<person name="Dietz F."/>
</authorList>
<dbReference type="PubMed" id="26845719"/>
<dbReference type="DOI" id="10.1515/hsz-2015-0273"/>
</citation>
<scope>INTERACTION WITH HDGF</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-324; LYS-370; LYS-377; LYS-513; LYS-577; LYS-589 AND LYS-624</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="submission" date="2006-06" db="PDB data bank">
<title>Solution structure of the RRM_1 domain of NCL protein.</title>
<authorList>
<consortium name="RIKEN structural genomics initiative (RSGI)"/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 478-566</scope>
</reference>
<comment type="function">
<text evidence="21">Nucleolin is the major nucleolar protein of growing eukaryotic cells. It is found associated with intranucleolar chromatin and pre-ribosomal particles. It induces chromatin decondensation by binding to histone H1. It is thought to play a role in pre-rRNA transcription and ribosome assembly. May play a role in the process of transcriptional elongation. Binds RNA oligonucleotides with 5'-UUAGGG-3' repeats more tightly than the telomeric single-stranded DNA 5'-TTAGGG-3' repeats.</text>
</comment>
<comment type="subunit">
<text evidence="19 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38">Identified in a IGF2BP1-dependent mRNP granule complex containing untranslated mRNAs (PubMed:17289661). Component of the SWAP complex that consists of NPM1, NCL/nucleolin, PARP1 and SWAP70 (By similarity). Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin (PubMed:10393184). Interacts with AICDA (By similarity). Interacts with APTX (PubMed:15044383). Interacts with C1QBP (PubMed:21536856). Interacts with ERBB4 (PubMed:20858735). Interacts (via C-terminus) with FMR1 isoform 6 (via N-terminus) (PubMed:24658146). Interacts with GZF1; this interaction is important for nucleolar localization of GZF1 (PubMed:17674968). Interacts with NSUN2 (PubMed:17215513). Interacts with NVL (PubMed:21474449). Interacts (via N-terminus domain) with SETX (PubMed:21700224). Interacts (via RRM1 and C-terminal RRM4/Arg/Gly-rich domains) with TERT; the interaction is important for nucleolar localization of TERT (PubMed:15371412). Interacts with WDR46 (PubMed:23848194). Interacts with ZFP36 (PubMed:20221403). Interacts with LRRC34 (By similarity). Interacts with RRP1B (PubMed:19710015). Interacts with HNRNPU; this interaction occurs during mitosis (PubMed:21242313). Interacts with RIOK1; RIOK1 recruits NCL to PRMT5 for symmetrically methylation (PubMed:21081503). Interacts with ZBTB7B (By similarity). Interacts with MDK; this interaction promotes NCL clustering and lateral movements of this complex into lipid rafts leading to MDK internalization (PubMed:12147681). Interacts with HDGF (isoform 1) (PubMed:26845719).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-1044254">
<id>Q9Y6D6</id>
<label>ARFGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-743313">
<id>P49407</id>
<label>ARRB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-714559">
<id>P32121</id>
<label>ARRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-2566375">
<id>PRO_0000005794</id>
<label>COL18A1</label>
<dbReference type="UniProtKB" id="P39060"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-389668">
<id>Q00987</id>
<label>MDM2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-350338">
<id>P35579</id>
<label>MYH9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-346967">
<id>P19338</id>
<label>NCL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-924893">
<id>Q9UQ80</id>
<label>PA2G4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-2683132">
<id>Q06710</id>
<label>PAX8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-446668">
<id>P61586</id>
<label>RHOA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-8308696">
<id>Q9CR42</id>
<label>Ankrd1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-1185167">
<id>Q8AZK7</id>
<label>EBNA-LP</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-346967">
<id>P19338</id>
</interactant>
<interactant intactId="EBI-6904388">
<id>PRO_0000037577</id>
<dbReference type="UniProtKB" id="P27958"/>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
<location>Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Localized in cytoplasmic mRNP granules containing untranslated mRNAs.</text>
</comment>
<comment type="PTM">
<text evidence="17">Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="31">Symmetrically methylated by PRMT5.</text>
</comment>
<comment type="sequence caution" evidence="40">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="BAC03738" version="1"/>
</conflict>
<text>Unlikely isoform. Aberrant splice sites.</text>
</comment>
<dbReference type="EMBL" id="M60858">
<property type="protein sequence ID" value="AAA59954.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK091742">
<property type="protein sequence ID" value="BAC03738.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC017104">
<property type="protein sequence ID" value="AAY24247.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33397.1"/>
<dbReference type="PIR" id="A35804">
<property type="entry name" value="A35804"/>
</dbReference>
<dbReference type="PIR" id="S53728">
<property type="entry name" value="S53728"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005372.2">
<property type="nucleotide sequence ID" value="NM_005381.2"/>
</dbReference>
<dbReference type="PDB" id="2FC8">
<property type="method" value="NMR"/>
<property type="chains" value="A=564-652"/>
</dbReference>
<dbReference type="PDB" id="2FC9">
<property type="method" value="NMR"/>
<property type="chains" value="A=478-565"/>
</dbReference>
<dbReference type="PDB" id="2KRR">
<property type="method" value="NMR"/>
<property type="chains" value="A=300-466"/>
</dbReference>
<dbReference type="PDBsum" id="2FC8"/>
<dbReference type="PDBsum" id="2FC9"/>
<dbReference type="PDBsum" id="2KRR"/>
<dbReference type="SMR" id="P19338"/>
<dbReference type="BioGRID" id="110771">
<property type="interactions" value="449"/>
</dbReference>
<dbReference type="CORUM" id="P19338"/>
<dbReference type="DIP" id="DIP-89N"/>
<dbReference type="ELM" id="P19338"/>
<dbReference type="IntAct" id="P19338">
<property type="interactions" value="172"/>
</dbReference>
<dbReference type="MINT" id="P19338"/>
<dbReference type="STRING" id="9606.ENSP00000318195"/>
<dbReference type="ChEMBL" id="CHEMBL4295725"/>
<dbReference type="MoonProt" id="P19338"/>
<dbReference type="iPTMnet" id="P19338"/>
<dbReference type="MetOSite" id="P19338"/>
<dbReference type="PhosphoSitePlus" id="P19338"/>
<dbReference type="SwissPalm" id="P19338"/>
<dbReference type="BioMuta" id="NCL"/>
<dbReference type="DMDM" id="90110781"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="P19338"/>
<dbReference type="SWISS-2DPAGE" id="P19338"/>
<dbReference type="CPTAC" id="CPTAC-936"/>
<dbReference type="EPD" id="P19338"/>
<dbReference type="jPOST" id="P19338"/>
<dbReference type="MassIVE" id="P19338"/>
<dbReference type="MaxQB" id="P19338"/>
<dbReference type="PaxDb" id="P19338"/>
<dbReference type="PeptideAtlas" id="P19338"/>
<dbReference type="PRIDE" id="P19338"/>
<dbReference type="ProteomicsDB" id="53647"/>
<dbReference type="TopDownProteomics" id="P19338"/>
<dbReference type="ABCD" id="P19338">
<property type="antibodies" value="5 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3779">
<property type="antibodies" value="832 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4691"/>
<dbReference type="Ensembl" id="ENST00000322723">
<property type="protein sequence ID" value="ENSP00000318195"/>
<property type="gene ID" value="ENSG00000115053"/>
</dbReference>
<dbReference type="GeneID" id="4691"/>
<dbReference type="KEGG" id="hsa:4691"/>
<dbReference type="UCSC" id="uc002vru.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4691"/>
<dbReference type="DisGeNET" id="4691"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000115053.15"/>
<dbReference type="GeneCards" id="NCL"/>
<dbReference type="HGNC" id="HGNC:7667">
<property type="gene designation" value="NCL"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000115053">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="164035">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P19338"/>
<dbReference type="OpenTargets" id="ENSG00000115053"/>
<dbReference type="PharmGKB" id="PA31469"/>
<dbReference type="eggNOG" id="KOG0123">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157437"/>
<dbReference type="HOGENOM" id="CLU_026300_1_0_1"/>
<dbReference type="InParanoid" id="P19338"/>
<dbReference type="KO" id="K11294"/>
<dbReference type="OMA" id="KNQSDPK"/>
<dbReference type="OrthoDB" id="1479417at2759"/>
<dbReference type="PhylomeDB" id="P19338"/>
<dbReference type="TreeFam" id="TF328499"/>
<dbReference type="PathwayCommons" id="P19338"/>
<dbReference type="Reactome" id="R-HSA-6791226">
<property type="pathway name" value="Major pathway of rRNA processing in the nucleolus and cytosol"/>
</dbReference>
<dbReference type="SIGNOR" id="P19338"/>
<dbReference type="BioGRID-ORCS" id="4691">
<property type="hits" value="645 hits in 887 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NCL">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P19338"/>
<dbReference type="GenomeRNAi" id="4691"/>
<dbReference type="Pharos" id="P19338">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P19338"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P19338">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000115053">
<property type="expression patterns" value="Expressed in testis and 123 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P19338">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P19338">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005938">
<property type="term" value="C:cell cortex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036464">
<property type="term" value="C:cytoplasmic ribonucleoprotein granule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990904">
<property type="term" value="C:ribonucleoprotein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005681">
<property type="term" value="C:spliceosomal complex"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0044547">
<property type="term" value="F:DNA topoisomerase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0048027">
<property type="term" value="F:mRNA 5'-UTR binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042162">
<property type="term" value="F:telomeric DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1990830">
<property type="term" value="P:cellular response to leukemia inhibitory factor"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0048026">
<property type="term" value="P:positive regulation of mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901838">
<property type="term" value="P:positive regulation of transcription of nucleolar large rRNA by RNA polymerase I"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd12403">
<property type="entry name" value="RRM1_NCL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd12404">
<property type="entry name" value="RRM2_NCL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd12405">
<property type="entry name" value="RRM3_NCL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd12406">
<property type="entry name" value="RRM4_NCL"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.70.330">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR034230">
<property type="entry name" value="Nucleolin_RRM1"/>
</dbReference>
<dbReference type="InterPro" id="IPR034233">
<property type="entry name" value="Nucleolin_RRM2"/>
</dbReference>
<dbReference type="InterPro" id="IPR034234">
<property type="entry name" value="Nucleolin_RRM3"/>
</dbReference>
<dbReference type="InterPro" id="IPR034235">
<property type="entry name" value="Nucleolin_RRM4"/>
</dbReference>
<dbReference type="InterPro" id="IPR012677">
<property type="entry name" value="Nucleotide-bd_a/b_plait_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035979">
<property type="entry name" value="RBD_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000504">
<property type="entry name" value="RRM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003954">
<property type="entry name" value="RRM_dom_euk"/>
</dbReference>
<dbReference type="Pfam" id="PF00076">
<property type="entry name" value="RRM_1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00360">
<property type="entry name" value="RRM"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00361">
<property type="entry name" value="RRM_1"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54928">
<property type="entry name" value="SSF54928"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS50102">
<property type="entry name" value="RRM"/>
<property type="match status" value="4"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="39">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Nucleolin" id="PRO_0000081691">
<location>
<begin position="2"/>
<end position="710"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="58"/>
<end position="65"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="75"/>
<end position="82"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="83"/>
<end position="90"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="91"/>
<end position="98"/>
</location>
</feature>
<feature type="repeat" description="5; truncated">
<location>
<begin position="99"/>
<end position="104"/>
</location>
</feature>
<feature type="repeat" description="6">
<location>
<begin position="105"/>
<end position="112"/>
</location>
</feature>
<feature type="repeat" description="7">
<location>
<begin position="120"/>
<end position="127"/>
</location>
</feature>
<feature type="repeat" description="8">
<location>
<begin position="128"/>
<end position="135"/>
</location>
</feature>
<feature type="domain" description="RRM 1" evidence="20">
<location>
<begin position="307"/>
<end position="383"/>
</location>
</feature>
<feature type="domain" description="RRM 2" evidence="20">
<location>
<begin position="393"/>
<end position="466"/>
</location>
</feature>
<feature type="domain" description="RRM 3" evidence="20">
<location>
<begin position="486"/>
<end position="560"/>
</location>
</feature>
<feature type="domain" description="RRM 4" evidence="20">
<location>
<begin position="572"/>
<end position="647"/>
</location>
</feature>
<feature type="region of interest" description="8 X 8 AA tandem repeats of X-T-P-X-K-K-X-X">
<location>
<begin position="58"/>
<end position="135"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="143"/>
<end position="171"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="185"/>
<end position="209"/>
</location>
</feature>
<feature type="compositionally biased region" description="Asp/Glu-rich (acidic)">
<location>
<begin position="234"/>
<end position="271"/>
</location>
</feature>
<feature type="compositionally biased region" description="Arg/Gly/Phe-rich">
<location>
<begin position="649"/>
<end position="698"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="9"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="28"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11">
<location>
<position position="34"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="41"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="42"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8 11 12 13 14">
<location>
<position position="67"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8 11 12">
<location>
<position position="69"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 11 13">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="84"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="92"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="96"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="102"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="113"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="116"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7 11 13">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="124"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 11 13">
<location>
<position position="145"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 13">
<location>
<position position="153"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 13 14">
<location>
<position position="184"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 13">
<location>
<position position="206"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="301"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="318"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="348"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="367"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="9">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="398"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="403"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="405"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="427"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="458"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="460"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="467"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="477"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="9">
<location>
<position position="513"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="19">
<location>
<position position="521"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 11 12 13">
<location>
<position position="563"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="572"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="9">
<location>
<position position="577"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 12 13 14">
<location>
<position position="580"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="591"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13 14">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="9">
<location>
<position position="646"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="656"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="660"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="666"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="670"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="673"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="679"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="18">
<location>
<position position="691"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="18">
<location>
<position position="694"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="19">
<location>
<position position="694"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15">
<location>
<position position="297"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="15">
<location>
<position position="297"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15">
<location>
<position position="324"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16">
<location>
<position position="324"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="370"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16">
<location>
<position position="377"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16">
<location>
<position position="513"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16">
<location>
<position position="577"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="15">
<location>
<position position="589"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="16">
<location>
<position position="589"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="16">
<location>
<position position="624"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11542691." id="VAR_046353">
<original>P</original>
<variation>L</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11542687." id="VAR_046354">
<original>P</original>
<variation>L</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11542689." id="VAR_046355">
<original>A</original>
<variation>V</variation>
<location>
<position position="174"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAC03738." ref="3" evidence="40">
<original>E</original>
<variation>G</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAA59954." ref="2" evidence="40">
<location>
<begin position="623"/>
<end position="626"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1." ref="1" evidence="40">
<location>
<begin position="625"/>
<end position="627"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="304"/>
<end position="306"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="308"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="316"/>
<end position="318"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="321"/>
<end position="333"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="338"/>
<end position="343"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="345"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="357"/>
<end position="365"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="377"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="388"/>
<end position="391"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="394"/>
<end position="399"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="406"/>
<end position="413"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="416"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="427"/>
<end position="435"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="439"/>
<end position="442"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="443"/>
<end position="445"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="446"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="460"/>
<end position="463"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="486"/>
<end position="492"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="499"/>
<end position="505"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="510"/>
<end position="513"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="524"/>
<end position="529"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="533"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="544"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="551"/>
<end position="557"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="565"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="572"/>
<end position="577"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="585"/>
<end position="590"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="596"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="608"/>
<end position="616"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="620"/>
<end position="630"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="641"/>
<end position="644"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="650"/>
<end position="652"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FC8"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FC9"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KRR"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17487921"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17924679"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000250"/>
<evidence key="18" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08199"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09405"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00176"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393184"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12147681"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15044383"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15371412"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17215513"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17289661"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17674968"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19710015"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20221403"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20858735"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21081503"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21242313"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21474449"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21536856"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21700224"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23848194"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24658146"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26845719"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7718615"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305"/>
<sequence length="710" mass="76614" checksum="C97F6E34E5CA6727" modified="2007-01-23" version="3">MVKLAKAGKNQGDPKKMAPPPKEVEEDSEDEEMSEDEEDDSSGEEVVIPQKKGKKAAATSAKKVVVSPTKKVAVATPAKKAAVTPGKKAAATPAKKTVTPAKAVTTPGKKGATPGKALVATPGKKGAAIPAKGAKNGKNAKKEDSDEEEDDDSEEDEEDDEDEDEDEDEIEPAAMKAAAAAPASEDEDDEDDEDDEDDDDDEEDDSEEEAMETTPAKGKKAAKVVPVKAKNVAEDEDEEEDDEDEDDDDDEDDEDDDDEDDEEEEEEEEEEPVKEAPGKRKKEMAKQKAAPEAKKQKVEGTEPTTAFNLFVGNLNFNKSAPELKTGISDVFAKNDLAVVDVRIGMTRKFGYVDFESAEDLEKALELTGLKVFGNEIKLEKPKGKDSKKERDARTLLAKNLPYKVTQDELKEVFEDAAEIRLVSKDGKSKGIAYIEFKTEADAEKTFEEKQGTEIDGRSISLYYTGEKGQNQDYRGGKNSTWSGESKTLVLSNLSYSATEETLQEVFEKATFIKVPQNQNGKSKGYAFIEFASFEDAKEALNSCNKREIEGRAIRLELQGPRGSPNARSQPSKTLFVKGLSEDTTEETLKESFDGSVRARIVTDRETGSSKGFGFVDFNSEEDAKAAKEAMEDGEIDGNKVTLDWAKPKGEGGFGGRGGGRGGFGGRGGGRGGRGGFGGRGRGGFGGRGGFRGGRGGGGDHKPQGKKTKFE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

